Ironwood Pharmaceuticals Inc (IRWD)
7.82
-0.26
(-3.22%)
USD |
NASDAQ |
Apr 26, 16:00
7.81
-0.01
(-0.13%)
After-Hours: 20:00
Ironwood Pharmaceuticals Net Income (Quarterly): -1.087M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.087M |
| September 30, 2023 | 15.32M |
| June 30, 2023 | -1.062B |
| March 31, 2023 | 45.71M |
| December 31, 2022 | 48.87M |
| September 30, 2022 | 50.32M |
| June 30, 2022 | 37.08M |
| March 31, 2022 | 38.80M |
| December 31, 2021 | 41.37M |
| September 30, 2021 | 55.84M |
| June 30, 2021 | 391.30M |
| March 31, 2021 | 39.93M |
| December 31, 2020 | 43.20M |
| September 30, 2020 | 34.42M |
| June 30, 2020 | 25.20M |
| March 31, 2020 | 3.345M |
| December 31, 2019 | 47.86M |
| September 30, 2019 | 20.65M |
| June 30, 2019 | 12.28M |
| March 31, 2019 | -59.28M |
| December 31, 2018 | -15.49M |
| September 30, 2018 | -174.35M |
| June 30, 2018 | -49.38M |
| March 31, 2018 | -43.14M |
| December 31, 2017 | 12.08M |
| Date | Value |
|---|---|
| September 30, 2017 | -32.30M |
| June 30, 2017 | -44.22M |
| March 31, 2017 | -52.50M |
| December 31, 2016 | -13.50M |
| September 30, 2016 | -33.20M |
| June 30, 2016 | -21.70M |
| March 31, 2016 | -13.30M |
| December 31, 2015 | -14.04M |
| September 30, 2015 | -47.39M |
| June 30, 2015 | -48.02M |
| March 31, 2015 | -33.22M |
| December 31, 2014 | -37.65M |
| September 30, 2014 | -41.99M |
| June 30, 2014 | -60.36M |
| March 31, 2014 | -49.63M |
| December 31, 2013 | -51.99M |
| September 30, 2013 | -61.78M |
| June 30, 2013 | -65.15M |
| March 31, 2013 | -93.90M |
| December 31, 2012 | -43.86M |
| September 30, 2012 | 47.64M |
| June 30, 2012 | -40.80M |
| March 31, 2012 | -35.60M |
| December 31, 2011 | -6.974M |
| September 30, 2011 | -20.63M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-1.062B
Minimum
Jun 2023
391.30M
Maximum
Jun 2021
-5.882M
Average
38.80M
Median
Mar 2022
Net Income (Quarterly) Benchmarks
| Societal CDMO Inc (DELISTED) | -0.786M |
| OPKO Health Inc | -66.48M |
| Inari Medical Inc | -4.665M |
| Kineta Inc | -2.654M |
| Moderna Inc | 217.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 117.55M |
| Total Expenses (Quarterly) | 74.34M |
| EPS Diluted (Quarterly) | -0.01 |
| Enterprise Value | 1.830B |
| Profit Margin (Quarterly) | -0.92% |
| Earnings Yield | -83.25% |
| Operating Earnings Yield | 12.57% |
| Normalized Earnings Yield | -10.88 |